Zobrazeno 1 - 10
of 253
pro vyhledávání: '"Anke Reinacher"'
Autor:
Ira Ekmekciu, Doreen Maria Zucha, Jens Christmann, Sarah Wisser, Vera Heuer, Buelent Sargin, Stephan Hollerbach, Christof Lamberti, Lothar Müller, Celine Lugnier, Berlinda Verdoodt, Robin Denz, Tobias Terzer, Inke Feder, Anke Reinacher-Schick, Andrea Tannapfel, Iris Tischoff
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionUnderstanding the mutational landscape of colon cancer (CC) is crucial for targeted therapy development. Microsatellite instability (MSI-H), rat sarcoma (RAS), and B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations (MT) are pi
Externí odkaz:
https://doaj.org/article/6e08f63b46b84380a72433c2eca25046
Autor:
Klara Dorman, Stefan Boeck, Robert J. Snijder, Jens T. Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas J. Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Publikováno v:
Current Oncology, Vol 30, Iss 6, Pp 5828-5834 (2023)
This analysis of the RASH trial (NCT01729481) aimed at gaining a better understanding of the “Burden of Therapy” (BOTh®TM) in pancreatic ductal adenocarcinoma (PDAC). In the RASH study, 150 patients with newly diagnosed metastatic PDAC were trea
Externí odkaz:
https://doaj.org/article/d4ab867951864e49ad0edeb7b333eb01
Autor:
Mortimer Gierthmuehlen, Nadine Höffken, Nina Timmesfeld, Kirsten Schmieder, Anke Reinacher-Schick
Publikováno v:
Pilot and Feasibility Studies, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Background Cancer-related fatigue (CRF) is defined as a “distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent ac
Externí odkaz:
https://doaj.org/article/bf53baadf3084e47b3319f74b8e96fcb
Autor:
Thilo Gambichler, Jonas Rüth, Silke Goesmann, Stefan Höxtermann, Marina Skrygan, Laura Susok, Jürgen C. Becker, Oliver Overheu, Wolfgang Schmidt, Anke Reinacher-Schick
Publikováno v:
Viruses, Vol 16, Iss 5, p 810 (2024)
In patients with COVID-19, broad panels of immune checkpoint molecules (ICPMs) and the purinergic signaling have not been studied in parallel. We aimed to perform in-depth immunophenotyping of major cell subsets present in human peripheral blood of C
Externí odkaz:
https://doaj.org/article/878c6a3945914e50a4b3dfc8f93469e1
Autor:
Stefanie Nöpel‐Dünnebacke, Hendrick Jütte, Robin Denz, Inke Sabine Feder, Anna‐Lena Kraeft, Celine Lugnier, Christian Teschendorf, Daniela Collette, Hinrich Böhner, Lars Engel, Lothar Mueller, Frank Hartmann, Ulrich Kaiser, Harald‐Robert Bruch, Stephan Hollerbach, Dirk Arnold, Nina Timmesfeld, Andrea Tannapfel, Anke Reinacher‐Schick
Publikováno v:
Cancer Medicine, Vol 11, Iss 8, Pp 1735-1744 (2022)
Abstract Background Colon cancer (CC) is a disease of elderly patients (pts.) with a median age of 73 years (yrs.). Lack of data about the effects of adjuvant chemotherapy (ACT) is caused by underrepresentation of this clinically relevant cohort in i
Externí odkaz:
https://doaj.org/article/8aa3bfd06c614788b5daca3996f260ea
Autor:
Clara Bessen, Carlos Plaza-Sirvent, Agit Simsek, Jaydeep Bhat, Corinna Marheinecke, Doris Urlaub, Petra Bonowitz, Sandra Busse, Sabrina Schumann, Elena Vidal Blanco, Adriane Skaletz-Rorowski, Norbert H. Brockmeyer, Oliver Overheu, Anke Reinacher-Schick, Simon Faissner, Carsten Watzl, Stephanie Pfaender, Anja Potthoff, Ingo Schmitz
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite the development of vaccines, which protect healthy people from severe and life-threatening Covid-19, the immunological responses of people with secondary immunodeficiencies to these vaccines remain incompletely understood. Here, we investigat
Externí odkaz:
https://doaj.org/article/abc6f45fd07d4397b50f0ec012acf870
Autor:
Thilo Gambichler, Nadine Schuleit, Laura Susok, Jürgen C. Becker, Christina H. Scheel, Christian Torres-Reyes, Oliver Overheu, Anke Reinacher-Schick, Wolfgang Schmidt
Publikováno v:
Viruses, Vol 15, Iss 9, p 1920 (2023)
With the end of the pandemic, COVID-19 has entered an endemic phase with expected seasonal spikes. Consequently, the implementation of easily accessible prognostic biomarkers for patients with COVID-19 remains an important area of research. In this m
Externí odkaz:
https://doaj.org/article/019e0dd69a4c40ccb710325b66138446
Autor:
Simon Faissner, Neele Heitmann, Carlos Plaza-Sirvent, Paulina Trendelenburg, Ulas Ceylan, Jeremias Motte, Clara Bessen, Doris Urlaub, Carsten Watzl, Oliver Overheu, Anke Reinacher-Schick, Kerstin Hellwig, Stephanie Pfaender, Ingo Schmitz, Ralf Gold
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveThe pandemic induced by SARS-CoV-2 has huge implications for patients with immunosuppression that is caused by disorders or specific treatments. Especially approaches targeting B cells via anti-CD20 therapy are associated with impaired humor
Externí odkaz:
https://doaj.org/article/16755a7f2810435ca56819e9ce9af063
Autor:
Mortimer Gierthmuehlen, Nadine Höffken, Nina Timmesfeld, Kirsten Schmieder, Anke Reinacher‑Schick
Publikováno v:
Pilot and Feasibility Studies, Vol 9, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/0cab78e2abb047049948559c5112caa9
Autor:
Sebastian Stasik, Marika Mende, Caroline Schuster, Sandra Mahler, Daniela Aust, Andrea Tannapfel, Anke Reinacher-Schick, Gustavo Baretton, Claudia Krippendorf, Martin Bornhäuser, Gerhard Ehninger, Gunnar Folprecht, Christian Thiede
Publikováno v:
Frontiers in Genetics, Vol 12 (2022)
The detection of plasma cell–free tumor DNA (ctDNA) is prognostic in colorectal cancer (CRC) and has potential for early prediction of disease recurrence. In clinical routine, ctDNA-based diagnostics are limited by the low concentration of ctDNA an
Externí odkaz:
https://doaj.org/article/cfe66e4dea3d4dd591e8825d0aa8db00